<!doctype html>
<html>

<head>
  <title>Quercus Theraputics</title>
  <title>Quercus Theraputics</title>
  <meta charset="utf-8" name="viewport" content="width=800px, initial-scale=1">
  <link href="css/styles.css" media="screen" rel="stylesheet" type="text/css" />
  <script src="https://ajax.googleapis.com/ajax/libs/jquery/3.3.1/jquery.min.js"></script>
  <script src="js/menu.js"></script>
  <script src="js/footer.js"></script>
</head>

<body>
  <div class="menu-container"></div>
  <div class="content-container">
    <div class="content">

  <table role="presentation" aria-label="Image and description table">
    <colgroup>
      <col />
      <col />
    </colgroup>
    <tbody>
      <!-- Row 1 -->
      <tr>
        <td>
          <figure>
            <img src="img/kehoe.png" alt="Arthur Kehoe, PharmD, MBA" />
            <figcaption>Arthur Kehoe, PharmD, MBA</figcaption>
          </figure>
        </td>
        <td class="desc">
          Art is President and CEO of Quercus Therapeutics since 2021.  
          He has been in healthcare and biotechnology for over twenty years, as a clinical pharmacist, 
          researcher, and company leader.  Before joining Quercus, Art was in an undisclosed location for several years.  
        </td>
      </tr>

      <!-- Row 2 -->
      <tr>
        <td>
          <figure>
            <img src="img/vanheft.png" alt="Thomas van Haft, DVM, PhD" />
            <figcaption>Thomas van Haft, DVM, PhD</figcaption>
          </figure>
        </td>
        <td class="desc">
          Thomas is Chief Scientific Officer at Quercus since 2019.  
          Before that he was a postdoctoral researcher and then Assistant Professor in the 
          lab of one of our founders, Professor Jonathan Jenkinson, at Harvard University.  Thomas trained 
          as a veterinarian in the Netherlands, earning his DVM from the University of Utrecht and a PhD in
          bioengineering and molecular biology from Radboud University in Nijmegen.  
        </td>
      </tr>

      <!-- Row 3 -->
      <tr>
        <td>
          <figure>
            <img src="img/white.png" alt="Scott White, JD, MS" />
            <figcaption>Scott White, JD, MS</figcaption>
          </figure>
        </td>
        <td class="desc">
          Scott has been Chief Financial Officer and Head of Legal and Intellectual Property at Quercus since 2019.  
          Prior to joining Quercus Scott held positions of increasing responsibility at several major pharmaceutical and biotechnology companies.  
        </td>
      </tr>

      <!-- Row 4 -->
      <tr>
        <td>
          <figure>
            <img src="img/mercer.png" alt="Anita Mercer, MSW" />
            <figcaption>Anita Mercer, MSW</figcaption>
          </figure>
        </td>
        <td class="desc">
          Anita is our Chief People Officer and head of our People & Organization line function, formerly known as Human Resources.  
          Before joining Quercus, Anita was VP, Human Resources, at Anonym Pharma.  
        </td>
      </tr>

      <tr>
        <td>
          <figure>
            <img src="img/perez.png" alt="Jorge Perez, PhD" />
            <figcaption>Jorge Perez, PhD</figcaption>
          </figure>
        </td>
        <td class="desc">
          Jorge is Sr. Vice President, Research & Development at Quercus.  He oversees our preclinical research, toxicology and preclinical safety, 
          pharmacokinetics, and clinical development organizations.  Before coming to Quercus in 2020, 
          Jorge was a postdoctoral researcher in the lab of our other founder, Prof. Harvey Hammerman, at Harvard.  
          Jorge earned his PhD in molecular biology at the University of Buenos Aires, Argentina.
        </td>
      </tr>

      <tr>
        <td>
          <figure>
            <img src="img/dupree.png" alt="Antoine (Tony) Dupree, PhD" />
            <figcaption>Antoine (Tony) Dupree, PhD</figcaption>
          </figure>
        </td>
        <td class="desc">
          Tony is head of Drug Manufacturing at Quercus.  Tony joined Quercus in 2023 after advancing to roles of 
          increasing responsibility at Biogen-Idec and before that at Millennium Therapeutics.  Tony has a PhD in biochemical engineering from Boston University.  
        </td>
      </tr>
    </tbody>

      <tr>
        <td>
          <figure>
            <img src="img/benny.png" alt="Benjamin (Benny) Mason, MD, PhD" />
            <figcaption>Benjamin (Benny) Mason, MD, PhD</figcaption>
          </figure>
        </td>
        <td class="desc">
            Benny recently joined Quercus as head of Clinical and Translational Development from Pfizer.  
            Benny is a neurologist and physician scientist who trained at Princeton, University of Pennsylvania, and Harvard. 
        </td>
      </tr>
    </tbody>



  </table>

    </div>
    <div class="footer-container"></div>
  </div>
</body>

</html>